Maccura guarantees RMB 27m for dealer to boost sales
Maccura Biotechnology Co., Ltd. has announced a new guarantee agreement with Industrial Bank Co., Ltd. Chengdu Branch to support its key dealer, Chengdu Ouruikang Biotechnology Co., Ltd. The guarantee, amounting to RMB 27 million, falls under a previously approved resolution by the company's board of directors and shareholders, which allows Maccura to provide guarantees for qualified dealers up to a total of RMB 350 million. The guarantee is a joint liability guarantee, valid for three years from the completion of the main contract's debt performance period.
Chengdu Ouruikang Biotechnology Co., Ltd., established on December 19, 2017, operates in the medical device and pharmaceutical wholesale sectors. As of September 30, 2025, Chengdu Ouruikang reported total assets of RMB 124,679,452.11 and total liabilities of RMB 104,798,342.01, with a debt-to-asset ratio of 84%. For the first nine months of 2025, the company achieved operating income of RMB 83,321,420.42 and a net profit of RMB 4,504,949.35.
As of the announcement date, Maccura Biotechnology and its controlling subsidiaries have a total external guarantee limit of RMB 1.15 billion, representing 18.06% of the company's net assets as of December 31, 2024. The actual outstanding guarantee balance is RMB 426.9166 million. The company confirms no overdue external guarantees, no external guarantees involved in litigation, and no losses to be borne due to adverse court rulings on guarantees.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Maccura Biotechnology publishes news
Free account required • Unsubscribe anytime